Rakesh K. Jain

Affiliations: 
1976-1983 Chemical and Biomedical Engineering Columbia University, New York, NY 
 1983-1991 Chemical and Biomedical Engineering Carnegie Mellon University, Pittsburgh, PA 
 1991- Engineering and Applied Sciences Harvard Medical School, Boston, MA, United States 
Area:
Biomedical Engineering
Website:
https://steelelabs.mgh.harvard.edu/rakesh_jain#pi_bio
Google:
""Rakesh Kumar Jain Harvard""
Bio:

https://steelelabs.mgh.harvard.edu/rakesh_jain/pi_bio
https://steele.mgh.harvard.edu/data/research_statements/1/Jain_Full_CV_1_1_2022.pdf
https://www.proquest.com/openview/89d8d85858f565f67f45e449d242abd4/1 "... my advisor Dr. James Wei, Allan P. Colburn Professor. I am greatly indebted to him for introducing me to the field of biomedical engineering and for his constant encouragement throughout the course of this investigation

Parents

Sign in to add mentor
Morton M. Denn grad student 1976 University of Delaware
Eli Ruckenstein grad student 1976
James Wei grad student 1976 University of Delaware (Chemistry Tree)
 (Dynamics of Drug Distribution in Solid Tumors)

Children

Sign in to add trainee
Charles Maldarelli grad student 1980 Columbia
Melody Swartz grad student 1998 MIT (Physics Tree)
Benjamin Diop-Frimpong grad student 2011 Harvard
Vikash P. Chauhan grad student 2012 Harvard
Kamila Naxerova grad student 2014 Harvard
Tao Sun post-doc (BME Tree)
Hadi T. Nia post-doc 2013-2019 Harvard Medical School (Biomechanics Tree)
Meenal Datta post-doc 2018-2021 Harvard Medical School (BME Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Datta M, Via LE, Dartois V, et al. (2024) Normalizing granuloma vasculature and matrix improves drug delivery and reduces bacterial burden in tuberculosis-infected rabbits. Proceedings of the National Academy of Sciences of the United States of America. 121: e2321336121
Datta M, Kennedy M, Siri S, et al. (2024) Mathematical model of oxygen, nutrient, and drug transport in Tuberculosis Granulomas. Plos Computational Biology. 20: e1011847
Chen J, Amoozgar Z, Liu X, et al. (2024) Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy. Cancer Immunology Research
Jain R, Krishnan S, Lee S, et al. (2023) Wnt inhibition alleviates resistance to immune checkpoint blockade in glioblastoma. Research Square
Iorgulescu JB, Ruthen N, Ahn R, et al. (2023) Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model. Frontiers in Immunology. 14: 1297932
Dong X, Ren J, Amoozgar Z, et al. (2023) Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice. Journal For Immunotherapy of Cancer. 11
Chen J, Amoozgar Z, Liu X, et al. (2023) Reprogramming Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy. Biorxiv : the Preprint Server For Biology
Datta M, Chatterjee S, Perez EM, et al. (2023) Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models. Proceedings of the National Academy of Sciences of the United States of America. 120: e2219199120
Martin JD, Lanning RM, Chauhan VP, et al. (2022) Multiphoton phosphorescence quenching microscopy reveals kinetics of tumor oxygenation during anti-angiogenesis and angiotensin signaling inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Ferraro GB, Ali A, Luengo A, et al. (2022) Author Correction: Fatty acid synthesis is required for breast cancer brain metastasis. Nature Cancer. 2: 1243
See more...